State Codes and Statutes

Statutes > Utah > Title-26 > Chapter-23b > 26-23b-105

26-23b-105. Pharmacy reporting requirements.
(1) Notwithstanding the provisions of Subsection 26-23b-103(1)(a), a pharmacist shallreport unusual drug-related events as described in Subsection (2).
(2) Unusual drug-related events that require a report include:
(a) an unusual increase in the number of prescriptions filled for antimicrobials;
(b) any prescription that treats a disease that has bioterrorism potential if that prescriptionis unusual or in excess of the expected frequency; and
(c) an unusual increase in the number of requests for information about or sales ofover-the-counter pharmaceuticals to treat conditions which may suggest the presence of one of theillnesses or conditions described in Section 26-23b-103 or 26-23b-104 and which are designatedby department rule.
(3) (a) A pharmacist shall submit the report required by this section within 24 hours afterthe pharmacist suspects, in his professional judgement, that an unusual drug-related event hasoccurred.
(b) If a pharmacy is part of a health care facility subject to the reporting requirements ofthis chapter, the pharmacist in charge shall make the report under this section on behalf of thehealth care facility.
(4) (a) The report required by this section shall be submitted in accordance withSubsection 26-23b-103(2)(a).
(b) A report shall include the name and location of the reporting pharmacist, the name andtype of pharmaceuticals that are the subject of the unusual increase in use, and if known, thesuspected illness or health condition that is the subject of the report.
(5) A pharmacist is subject to the penalties under Subsection 26-23b-103(3) for failing tomake a report required by this section.

Enacted by Chapter 155, 2002 General Session

State Codes and Statutes

Statutes > Utah > Title-26 > Chapter-23b > 26-23b-105

26-23b-105. Pharmacy reporting requirements.
(1) Notwithstanding the provisions of Subsection 26-23b-103(1)(a), a pharmacist shallreport unusual drug-related events as described in Subsection (2).
(2) Unusual drug-related events that require a report include:
(a) an unusual increase in the number of prescriptions filled for antimicrobials;
(b) any prescription that treats a disease that has bioterrorism potential if that prescriptionis unusual or in excess of the expected frequency; and
(c) an unusual increase in the number of requests for information about or sales ofover-the-counter pharmaceuticals to treat conditions which may suggest the presence of one of theillnesses or conditions described in Section 26-23b-103 or 26-23b-104 and which are designatedby department rule.
(3) (a) A pharmacist shall submit the report required by this section within 24 hours afterthe pharmacist suspects, in his professional judgement, that an unusual drug-related event hasoccurred.
(b) If a pharmacy is part of a health care facility subject to the reporting requirements ofthis chapter, the pharmacist in charge shall make the report under this section on behalf of thehealth care facility.
(4) (a) The report required by this section shall be submitted in accordance withSubsection 26-23b-103(2)(a).
(b) A report shall include the name and location of the reporting pharmacist, the name andtype of pharmaceuticals that are the subject of the unusual increase in use, and if known, thesuspected illness or health condition that is the subject of the report.
(5) A pharmacist is subject to the penalties under Subsection 26-23b-103(3) for failing tomake a report required by this section.

Enacted by Chapter 155, 2002 General Session


State Codes and Statutes

State Codes and Statutes

Statutes > Utah > Title-26 > Chapter-23b > 26-23b-105

26-23b-105. Pharmacy reporting requirements.
(1) Notwithstanding the provisions of Subsection 26-23b-103(1)(a), a pharmacist shallreport unusual drug-related events as described in Subsection (2).
(2) Unusual drug-related events that require a report include:
(a) an unusual increase in the number of prescriptions filled for antimicrobials;
(b) any prescription that treats a disease that has bioterrorism potential if that prescriptionis unusual or in excess of the expected frequency; and
(c) an unusual increase in the number of requests for information about or sales ofover-the-counter pharmaceuticals to treat conditions which may suggest the presence of one of theillnesses or conditions described in Section 26-23b-103 or 26-23b-104 and which are designatedby department rule.
(3) (a) A pharmacist shall submit the report required by this section within 24 hours afterthe pharmacist suspects, in his professional judgement, that an unusual drug-related event hasoccurred.
(b) If a pharmacy is part of a health care facility subject to the reporting requirements ofthis chapter, the pharmacist in charge shall make the report under this section on behalf of thehealth care facility.
(4) (a) The report required by this section shall be submitted in accordance withSubsection 26-23b-103(2)(a).
(b) A report shall include the name and location of the reporting pharmacist, the name andtype of pharmaceuticals that are the subject of the unusual increase in use, and if known, thesuspected illness or health condition that is the subject of the report.
(5) A pharmacist is subject to the penalties under Subsection 26-23b-103(3) for failing tomake a report required by this section.

Enacted by Chapter 155, 2002 General Session